Please login to the form below

Not currently logged in
Email:
Password:

Zosano appoints Chris Krueger as chief business officer

He joins from Ardea Biosciences

Chris Kruger has joined Zosano Pharma as chief business officer.

He joins the US-based biopharma from Ardea Biosciences, where he served as senior VP and chief business officer.

During his time at Ardea, Krueger completed a $407m global partnership with Bayer HealthCare.

In his new role, he will be responsible for business development, legal, and investor relations activities of Zosano as it prepares to expand its efforts in developing drug's utilising its novel drug delivery system.

Additional previous roles Krueger has held include senior executive positions at Protemix, Xencor, X–Ceptor Therapeutics and Aurora Biosciences.

His experience includes a broad range of transactions, including licensing, strategic alliances, mergers and acquisitions and equity and debt financings.

"It's exciting for me to join the Zosano team as the company enters its next stage of corporate growth," said Krueger.

"With its novel transdermal drug delivery system, Zosano is poised to develop therapeutic products through its own efforts and through strategic collaborations."

12th April 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics